EX-31.2 2 phio_ex3102.htm CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

SECURITIES EXCHANGE ACT OF 1934 RULES 13a-14(a) AND 15d-14(a)

AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Gerrit Dispersyn, certify that:

 

  1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Phio Pharmaceuticals Corp.; and

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

 

Dated: April 29, 2022

   

/s/ Gerrit Dispersyn

  
Gerrit Dispersyn, Dr. Med. Sec.  
President and Chief Executive Officer  
(as Principal Executive and Financial Officer)